RPRX: Accelerated growth via innovative deals, AI-driven insights, and expanding global partnerships
Achieved capital deployment targets ahead of schedule, driven by robust deal flow and new opportunities in big pharma and China. Innovative R&D co-funding and synthetic royalty structures are fueling growth, while AI-powered data platforms enhance investment quality and partner value. Double-digit…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.